MPLT EBITDA Growth

Maplight Therapeutics Inc · EBITDA Growth

MPLT logo

MPLT EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-153.52%
MPLT TTM EBITDA YoY % (-50.97% → -153.52%)
High-resolution chart · PNG

MPLT ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Maplight Therapeutics Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-153.52%
-147.8147%
-108.8646%
-50.9668%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.